(Q40816622)

24 September 2017

1 reference

title

Problems and pitfalls of sulphonylurea therapy in older patients (English)

1 reference

24 September 2017

D A Robertson

1

1 reference

24 September 2017

P D Home

series ordinal

2

1 reference

24 September 2017

publication date

1 November 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

3

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

510-524

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199303060-00005

24 September 2017

exact match

0 references

cites work

Mechanism of action of the second-generation sulfonylurea glipizide

1 reference

12 December 2020

Drug-induced hypoglycemia. A review based on 473 cases

1 reference

12 December 2020

Is it a hypo? Knowledge of the symptoms of hypoglycaemia in elderly diabetic patients

1 reference

12 December 2020

Need for glucagon in severe hypoglycaemia induced by sulphonylurea drugs.

1 reference

12 December 2020

Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics

1 reference

12 December 2020

Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects.

1 reference

12 December 2020

Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus

1 reference

12 December 2020

[The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984]

1 reference

12 December 2020

The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs

1 reference

12 December 2020

Pemphigus vulgaris precipitated by glibenclamide therapy

1 reference

12 December 2020

Prescribing for the elderly: Part II. Prescribing patterns: differences due to age.

1 reference

12 December 2020

Use of sulfonylurea agents in older diabetic patients

1 reference

12 December 2020

Des 4-trans-hydroxy-glibenclamide show hypoglycemic activity?

1 reference

12 December 2020

Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Therapeutic equivalence of once- and thrice-daily glipizide.

1 reference

12 December 2020

Impaired effect of sulfonylurea following increased dosage.

1 reference

12 December 2020

Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose

1 reference

12 December 2020

Benefits and Risks With Glyburide and Glipizide in Elderly NIDDM Patients

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

Severe Hypoglycaemia During Treatment with Glipizide

1 reference

12 December 2020

Sulfonylureas. Why, which, and how?

1 reference

12 December 2020

Glipizide pharmacokinetics: effects of age, diabetes, and multiple dosing

1 reference

12 December 2020

Oral hypoglycemic agents

1 reference

12 December 2020

The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.

1 reference

12 December 2020

Mechanism of improvement in glucose metabolism after chronic glyburide therapy

1 reference

12 December 2020

Chronic sulfonylurea therapy augments basal and meal-stimulated insulin secretion while attenuating insulin responses to sulfonylurea per se

1 reference

12 December 2020

Sulphonylureas and hypoglycaemia

1 reference

12 December 2020

Potentiation of Insulin Action by a Sulfonylurea in Primary Cultures of Hepatocytes from Normal and Diabetic Rats

1 reference

12 December 2020

Sulfonylureas in NIDDM.

1 reference

12 December 2020

Glibenclamide-associated hypoglycaemia: a report on 57 cases

1 reference

12 December 2020

Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure.

1 reference

12 December 2020

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

1 reference

12 December 2020

Efficacy of glyburide in diabetics poorly controlled on first-generation oral hypoglycemics

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of glyburide in young and elderly nondiabetic adults.

1 reference

12 December 2020

Glipizide pharmacokinetics in young and elderly volunteers

1 reference

12 December 2020

When to use insulin in the maturity onset diabetic

1 reference

12 December 2020

Oral hypoglycaemics for diabetes: when and which?

1 reference

12 December 2020

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

1 reference

12 December 2020

Hemobiological activity of gliclazide in diabetes mellitus

1 reference

12 December 2020

Drug-induced hypoglycemia. A review of 1418 cases.

1 reference

12 December 2020

Sulphonylureas in the treatment of non-insulin-dependent diabetes

1 reference

12 December 2020

Evaluation of glipizide and glyburide in a health maintenance organization

1 reference

12 December 2020

Medication compliance in the elderly

1 reference

12 December 2020

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results

1 reference

12 December 2020

Reduced thirst after water deprivation in healthy elderly men.

1 reference

12 December 2020

88 severe incidents of hypoglycemia in patients under treatment with sulfonylurea compounds. Results of a survey throughout Switzerland during 1968 and 1969

1 reference

12 December 2020

Diabetes in the elderly: diagnosis, pathogenesis, and therapy.

1 reference

12 December 2020

Pharmacokinetic changes in aging

1 reference

12 December 2020

Epidemiology of diabetes mellitus among the elderly in the United States

1 reference

12 December 2020

Health care of the elderly

1 reference

12 December 2020

Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects

1 reference

12 December 2020

Diabetes in patients with hypertension receiving pharmacological treatment

1 reference

12 December 2020

Relative importance to elderly patients of effectiveness, adverse effects, convenience and cost of antihypertensive medications. A pilot study

1 reference

12 December 2020

Impaired beta-cell responses improve when fasting blood glucose concentration is reduced in non-insulin-dependent diabetes.

1 reference

12 December 2020

Undesired effects of the sulphonylurea drugs.

1 reference

12 December 2020

Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide

1 reference

12 December 2020

The management of non-insulin-dependent diabetes mellitus in the elderly.

1 reference

12 December 2020

Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.

1 reference

12 December 2020

Oral Hypoglycemic Agent Update

1 reference

12 December 2020

Aging and drug disposition: an update

1 reference

12 December 2020

Drug therapy: drug disposition in old age.

1 reference

12 December 2020

Insulin for the non-insulin dependent?

1 reference

12 December 2020

Blood Sugar Lowering Effects of Chlorpropamide and Tolbutamide: A Double Blind Cooperative Study

1 reference

12 December 2020

Metabolic and clinical effects of glibenclamide

1 reference

12 December 2020

Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study

1 reference

12 December 2020

Modulation by a sulfonylurea of insulin-dependent glycogenesis, but not of insulin binding, in cultured rat hepatocytes. Evidence for a postreceptor mechanism of action

1 reference

12 December 2020

The Management of Diabetes Mellitus in Older Individuals

1 reference

12 December 2020

Metabolic studies in diabetics on tolbutamide. Comparison of a single dose with a divided dose regimen

1 reference

12 December 2020

Infection and diabetes: the case for glucose control

1 reference

12 December 2020

Mechanisms of sulfonylurea-induced insulin release

1 reference

12 December 2020

Long-term safety and efficacy of glipizide

1 reference

12 December 2020

In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport

1 reference

12 December 2020

Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view

1 reference

12 December 2020

Bedtime insulin added to daytime sulfonylureas improves glycemic control in uncontrolled type II diabetes.

1 reference

12 December 2020

Chlorpropamide-induced hyponatremia in the veteran population

1 reference

12 December 2020

Chlorpropamide-induced hypoglycemia: successful treatment with diazoxide

1 reference

12 December 2020

Treatment of type II diabetes

1 reference

12 December 2020

Rational use of sulfonylureas

1 reference

12 December 2020

The relationships between dose and concentration of tolbutamide and insulin and glucose responses in patients with non-insulin-dependent diabetes.

1 reference

12 December 2020

Diuretic Action of Three Sulfonylurea Drugs

1 reference

12 December 2020

Chlorpropamide alcohol flushing: a normal response?

1 reference

12 December 2020

Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

What is the benefit of increasing the sulfonylurea dose?

1 reference

12 December 2020

The second-generation sulfonylureas: change or progress?

1 reference

12 December 2020

Diabetes in the elderly: diagnosis and epidemiology

1 reference

12 December 2020

Hyperglycaemia and absorption of sulphonylurea drugs

1 reference

12 December 2020

Morning or bed-time insulin with or without glibenclamide in elderly Type 2 diabetic patients unresponsive to oral antidiabetic agents

1 reference

12 December 2020

Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes.

1 reference

12 December 2020

10.2165/00002512-199303060-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1025760310

0 references

1 reference